Literature DB >> 9456307

Sequences of intestinal and hepatic cytochrome P450 3A4 cDNAs are identical.

K S Lown1, M Ghosh, P B Watkins.   

Abstract

Cytochrome P450 (CYP or P450) 3A4 is known to be the major P450 expressed in the liver. More recently, CYP3A4 was also shown to be the major P450 in the intestine, where it plays an important role in the metabolism of some orally administered drugs. However, studies examining the catalytic properties of CYP3A4 have been largely based on the use of CYP3A4 enzyme obtained from liver or recombinant protein expressed from hepatic cDNA. To investigate whether intestinal and hepatic CYP3A4 enzymes are identical, we determined the sequences of intestinal CYP3A4 cDNAs. Compared with the published sequence for hepatic CYP3A4, we found a single base pair difference in the 3' untranslated region of intestinal cDNA from three individuals. We found this same base pair difference in cDNA obtained from the livers of three additional subjects. We conclude that hepatic and intestinal CYP3A4 cDNAs are identical and that the proteins expressed in these two tissues are therefore likely to be the same.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9456307

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  10 in total

Review 1.  The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?

Authors:  Margaret M Doherty; William N Charman
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein.

Authors:  Y Zhang; L Z Benet
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 3.  Cytochrome P450 3A: ontogeny and drug disposition.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

4.  The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update.

Authors:  Wenpeng Zhang; Yanyan Li; Peng Zou; Man Wu; Zhenqing Zhang; Tao Zhang
Journal:  AAPS J       Date:  2016-05-16       Impact factor: 4.009

Review 5.  The influence of age and sex on the clearance of cytochrome P450 3A substrates.

Authors:  Monette M Cotreau; Lisa L von Moltke; David J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

6.  The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans.

Authors:  R Sandström; T W Knutson; L Knutson; B Jansson; H Lennernäs
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

7.  Influence of verapamil on the pharmacokinetics of the antiparasitic drugs ivermectin and moxidectin in sheep.

Authors:  M B Molento; A Lifschitz; J Sallovitz; C Lanusse; R Prichard
Journal:  Parasitol Res       Date:  2003-11-21       Impact factor: 2.289

Review 8.  Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations.

Authors:  Ibrahim Ince; Catherijne A J Knibbe; Meindert Danhof; Saskia N de Wildt
Journal:  Clin Pharmacokinet       Date:  2013-05       Impact factor: 6.447

Review 9.  Application and impact of population pharmacokinetics in the assessment of antiretroviral pharmacotherapy.

Authors:  Jeffrey S Barrett; Line Labbé; Marc Pfister
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

10.  Direct On-Chip Differentiation of Intestinal Tubules from Induced Pluripotent Stem Cells.

Authors:  Elena Naumovska; Germaine Aalderink; Christian Wong Valencia; Kinga Kosim; Arnaud Nicolas; Stephen Brown; Paul Vulto; Kai S Erdmann; Dorota Kurek
Journal:  Int J Mol Sci       Date:  2020-07-14       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.